Many rare movement disorders present with a complex combination of symptoms. Gain insight into the process your colleagues leverage and clues they look for to diagnose rare movement disorders.

Watch it on the #MDSCongress Virtual Platform. loom.ly/wZTEn3Q

Receive a comprehensive overview of current #DBS techniques at the MDS-PAS 3rd School on Neuromodulation for Movement Disorders. loom.ly/seO3CHE

NEW EXCLUSIVE VIDEO (CME Accredited):

Watch our latest 1:1 expert interview: Levodopa Mythology featuring Alberto J Espay

Direct link: cutt.ly/UNilc0U

#Neurology #Parkinsons #Parkinsons Disease #OruenCNS #Levodopa

Some disrupted miRNA pathways in HD have been associated with neuroprotective capabilities. A scaffold protein, TRAX, was upregulated during HD pathogenesis. Learn more about the role of TRAX in this recent study. loom.ly/2pLvQKM

Answer to yesterday's poll: C. Dystonia was first used by Hermann Oppenheim in his 1911 publication that described the sustained spasm of dystonia musculorum deformans. loom.ly/x1UqCCg

Observations of various movement disorders like PD, tremor and dystonia are often described in ancient texts. Descriptions of dystonia may have been described in writings of Hippocrates, described as “a stiff and painful neck.” However, when was the term dystonia first used?

TorsinA protein is a known contributor to DYT1 dystonia, however, the role of a-synuclein in dystonia is not widely known. This study found a decrease in a-synuclein and SNARES, which were thought to contribute to the synaptic dysfunction in DYT1 dystonia loom.ly/m3_gdGs

The latest issue of Movement Disorders Journal is now available with updates on α-Synuclein, common variants in multiple system atrophy and neuroprotection for HD. loom.ly/6xId3XU

This study sought to investigate the subcortical and cortical field potentials in patients with #PD with or without dystonia undergoing DBS. Patients with PD with dystonia displayed greater M1 beta power and STN low-frequency power. loom.ly/1EM8Qgo

Answer to yesterday's poll: B. Complex dystonias manifest in syndromes with other neurologic or systemic presentations (ie. Mitochondrial disorders), whereas combined dystonia describes dystonia in conjunction with other movement disorders (ie. PD). loom.ly/WvKWu0c

This riveting session contains timely presentations and discussions while we are in the “learning phase” of understanding encephalitis and its relationship with COVID-19.

Watch it on the #MDSCongress Virtual Platform. loom.ly/f_MqR3c

Dystonia can manifest in many forms, which are often described as isolated, combined and complex dystonia. Does the following sentence describe combined or complex dystonia: Dystonias that are accompanied by neurologic or systemic manifestations beyond movement disorders.

OUT NOW!: Reflections on #Parkinsons Podcast series 2: ABC of #PD . In EP3 Prof Werner Poewe & Prof Bas Bloem look into the letter F and discuss – #Fluctuations & #Fatigue .

All links to stream can be found here: cutt.ly/FBLEL8u

Parkinson's Europe MDS

Join us for session 4: Functional Movement Disorders.
Interactive sessions: Thursday, November 10. loom.ly/cu3DkGE